4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001708138-20-000108
EVP Research sold 6,628 shares at an average $542.73 ($3,597,188)
- EVP Research gave up 7,108 shares (to pay taxes)
- EVP Research acquired 13,736 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
MURPHY ANDREW J · EVP Research
Table I: Non-derivative
21 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-16 | Exercise or conversion : show line 1 in the form | +13,736 | $30.63 | $420,734 | 60,872 | D |
| 2020-11-16 | Shares withheld for taxes : show line 2 in the form | −7,108 | $561.39 | $3,990,360 | 53,764 | D |
| 2020-11-17 | Sale : show line 3 in the form | −743 | $536.68 | $398,753 | 53,021 | D |
| 2020-11-17 | Sale : show line 4 in the form | −229 | $537.38 | $123,060 | 52,792 | D |
| 2020-11-17 | Sale : show line 5 in the form | −591 | $538.37 | $318,177 | 52,201 | D |
| 2020-11-17 | Sale : show line 6 in the form | −42 | $539.87 | $22,675 | 52,159 | D |
| 2020-11-17 | Sale : show line 7 in the form | −1,442 | $540.49 | $779,387 | 50,717 | D |
| 2020-11-17 | Sale : show line 8 in the form | −812 | $541.42 | $439,633 | 49,905 | D |
| Open-market sales · 6,628 sh · avg $542.73 · $3,597,188 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-11-16 | Exercise or conversion : show line 22 in the form Non-Qualified Stock Option (right to buy) | −13,736 | $30.63 | 2020-12-14 | 13,736 | 0 | D |
Loading xslF345X03/edgardoc.xml…